What Are the Best Questionnaires To Capture Anorectal Function After Surgery in Rectal Cancer?

Current Colorectal Cancer Reports

Volumn 11, Issue 1, 2015, Pages 37-43

  Chen, Tina Yen Ting ^a   Emmertsen, Katrine J ^a   Laurberg, Søren ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anorectal dysfunction; Anorectal function; Anterior resection syndrome; Assessment; Bowel dysfunction; Evaluation; Functional outcome; Instrument; Low anterior resection; Low anterior resection syndrome; Measurement; Questionnaire; Rectal cancer; Rectal cancer surgery; Scoring system; Sphincter preserving surgery; Tool

Indexed keywords

EID: 84935870770     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-014-0217-6     Document Type: Review

References (68)

1. International Agency for Research on Cancer. Colorectal cancer. Estimated incidence, mortality and prevalence worldwide in 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed Jan 2014.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
3. Enker WE. Total mesorectal excision—the new golden standard of surgery for rectal cancer. Ann Med. 1997;29:127–33.
4. Kapiteijn E, Putter H, van de Velde CJH, et al. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg. 2002;89:1142–9.
5. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575–82.
6. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–20.
7. Rutter CM, Johnson EA, Feuer EJ, et al. Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst. 2013;105:1806–13.
8. Engel AF, Oomen JL, Eijsbouts QA, et al. Nationwide decline in annual numbers of abdomino-perineal resections: effect of a successful national trial? Color Dis. 2003;5:180–4.
9. Marwan K, Staples MP, Thursfield V, et al. The rate of abdominoperineal resections for rectal cancer in the state of Victoria, Australia: a population-based study. Dis Colon Rectum. 2010;53:1645–51.
10. Tilney HS, Heriot AG, Purkayastha S, et al. A national perspective on the decline of abdominoperineal resection for rectal cancer. Ann Surg. 2008;247:77–84.
11. Stephens JH, Hewett PJ. Clinical trial assessing VSL#3 for the treatment of anterior resection syndrome. ANZ J Surg. 2012;82:420–7.
12. Scheer AS, Boushey RP, Liang S, et al. The long-term gastrointestinal functional outcomes following curative anterior resection in adults with rectal cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2011;54:1589–97. The authors identify and demonstrate that long-term bowel function after rectal cancer surgery is inconsistently assessed due to the lack of a common definition of LARS, and the use of heterogeneous, nonvalidated instruments.
13. Bryant CL, Lunniss PJ, Knowles CH, et al. Anterior resection syndrome. Lancet Oncol. 2012;13:e403–8. The authors recognize that there is no adequate instrument for measuring LARS in widespread use, and suggest a pragmatic definition of LARS to address the lack of a common definition.
14. Havenga K, Maas CP, DeRuiter MC, et al. Avoiding long-term disturbance to bladder and sexual function in pelvic surgery, particularly with rectal cancer. Semin Surg Oncol. 2000;18:235–43.
15. Havenga K, Enker WE, McDermott K, et al. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg. 1996;182:495–502.
16. Engel J, Kerr J, Schlesinger-Raab A, et al. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg. 2003;238:203–13.
17. Jayne DG, Brown JM, Thorpe H, et al. Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg. 2005;92:1124–32.
18. Loos M, Quentmeier P, Schuster T, et al. Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20:1816–28.
19. Brown LC, Atherton PJ, Neben-Wittich MA, et al. Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1. Support Care Cancer. 2013;21:2869–77.
20. Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199–206.
21. Lundby L, Krogh K, Jensen VJ, et al. Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis Colon Rectum. 2005;48:1343–52.
22. Dahlberg M, Glimelius B, Graf W, et al. Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum. 1998;41:543–51.
23. Bregendahl S, Emmertsen KJ, Lous J, et al. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Color Dis. 2013;15:1130–9.
24. Hallböök O, Sjödahl R. Surgical approaches to obtaining optimal bowel function. Semin Surg Oncol. 2000;18:249–58.
25. Pedersen IK, Christiansen J, Hint K, et al. Anorectal function after low anterior resection for carcinoma. Ann Surg. 1986;204:133–5.
26. Emmertsen KJ, Laurberg S. Rectal Cancer Function Study Group. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013;100:1377–87.
27. Fazio VW, Zutshi M, Remzi FH, et al. A randomized multicenter trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg. 2007;246:481–90.
28. Kakodkar R, Gupta S, Nundy S. Low anterior resection with total mesorectal excision for rectal cancer: functional assessment and factors affecting outcome. Color Dis. 2006;8:650–6.
29. Ho YH, Low D, Goh HS. Bowel function survey after segmental colorectal resections. Dis Colon Rectum. 1996;39:307–10.
30. Desnoo L, Faithfull S. A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery. Eur J Cancer Care (Engl). 2006;15:244–51.
31. Batignani G, Monaci I, Ficari F, et al. What affects continence after anterior resection of the rectum? Dis Colon Rectum. 1991;34:329–35.
32. Grumann MM, Noack EM, Hoffmann IA, et al. Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg. 2001;233:149–56.
33. Camilleri-Brennan J, Steele RJ. Quality of life after treatment for rectal cancer. Br J Surg. 1998;85:1036–43.
34. Camilleri-Brennan J, Ruta DA, Steele RJ. Patient generated index: new instrument for measuring quality of life in patients with rectal cancer. World J Surg. 2002;26:1354–9.
35. Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 2012;12, CD004323.
36. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 4th ed. New York: Oxford University Press; 2008.
37. McDowell I. Measuring health: a guide to rating scales and questionnaires. 3rd ed. Oxford: Oxford University Press; 2006.
38. Chen TY, Emmertsen KJ, Laurberg S. Bowel dysfunction after rectal cancer treatment: a study comparing the specialist's versus patient's perspective. BMJ Open. 2014;4:e003374.
39. American Medical Systems. Fecal incontinence scoring system. Minnetonka: American Medical Systems; 1996.
40. Atherton PJ, Halyard MY, Sloan JA, et al. Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA. Support Care Cancer. 2013;21:1193–9.
41. Kollmorgen CF, Meagher AP, Wolff BG, et al. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg. 1994;220:676–82.
42. Kozelsky TF, Meyers GE, Sloan JA, et al. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol. 2003;21:1669–74.
43. Martenson JA, Halyard MY, Sloan JA, et al. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol. 2008;26:5248–53.
44. Martenson JA, Bollinger JW, Sloan JA, et al. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial. J Clin Oncol. 2000;18:1239–45.
45. Whistance RN, Conroy T, Chie W, et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer. 2009;45:3017–26.
46. Rockwood TH, Church JM, Fleshman JW, et al. Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9–17.
47. Yoo HJ, Kim JC, Eremenco S, et al. Quality of life in colorectal cancer patients with colectomy and the validation of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C), version 4. J Pain Symptom Manag. 2005;30:24–32.
48. O'Connor R. Measuring quality of life in health. London: Churchill Livingstone; 2004.
49. Joyce CRB, O'Boyle CA, McGee HM. Individual quality of life: approaches to conceptualisation and assessment. Amsterdam: Harwood; 1999.
50. Gosselink MP, West RL, Kuipers EJ, et al. Integrity of the anal sphincters after pouch-anal anastomosis: evaluation with three-dimensional endoanal ultrasonography. Dis Colon Rectum. 2005;48:1728–35.
51. Chamlou R, Parc Y, Simon T, et al. Long-term results of intersphincteric resection for low rectal cancer. Ann Surg. 2007;246:916–22.
52. Bittorf B, Stadelmaier U, Göhl J, et al. Functional outcome after intersphincteric resection of the rectum with coloanal anastomosis in low rectal cancer. Eur J Surg Oncol. 2004;30:260–5.
53. Bretagnol F, Rullier E, Laurent C, et al. Comparison of functional results and quality of life between intersphincteric resection and conventional coloanal anastomosis for low rectal cancer. Dis Colon Rectum. 2004;47:832–8.
54. Matzel KE, Stadelmaier U, Bittorf B, et al. Bilateral sacral spinal nerve stimulation for fecal incontinence after low anterior rectum resection. Int J Colorectal Dis. 2002;17:430–4.
55. Pucciani F, Ringressi MN, Redditi S, et al. Rehabilitation of fecal incontinence after sphincter-saving surgery for rectal cancer: encouraging results. Dis Colon Rectum. 2008;51:1552–8.
56. Welsh F, McFall M, Mitchell G, et al. Pre-operative short-course radiotherapy is associated with faecal incontinence after anterior resection. Color Dis. 2003;5:563–8.
57. Gosselink MP, Zimmerman DD, West RL, et al. The effect of neo-rectal wall properties on functional outcome after colonic J-pouch-anal anastomosis. Int J Colorectal Dis. 2007;22:1353–60.
58. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36:77–97.
59. Vaizey CJ, Carapeti E, Cahill JA, et al. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44:77–80.
60. Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence. Dis Colon Rectum. 1999;42:1525–32.
61. Maeda Y, Parés D, Norton C, et al. Does the St. Mark's incontinence score reflect patients” perceptions? A review of 390 patients. Dis Colon Rectum. 2008;51:436–42.
62. Seong MK, Jung SI, Kim TW, et al. Comparative analysis of summary scoring systems in measuring fecal incontinence. J Korean Surg Soc. 2011;81:326–31.
63. Krogh K, Christensen P, Sabroe S, et al. Neurogenic bowel dysfunction score. Spinal Cord. 2006;44:625–31.
64. Temple LK, Bacik J, Savatta SG, et al. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum. 2005;48:1353–65. The authors introduce a comprehensive, detailed, and psychometrically robust instrument for examining bowel function after surgery in rectal cancer.
65. Zotti P, Del Bianco P, Serpentini S, et al. Validity and reliability of the MSKCC Bowel Function instrument in a sample of Italian rectal cancer patients. Eur J Surg Oncol. 2011;37:589–96.
66. Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255:922–8. The authors introduce a practical and psychometrically robust instrument for examining bowel function after surgery in rectal cancer, which reflects impact on QOL.
67. Juul T, Ahlberg M, Biondo S, et al. Low anterior resection syndrome and quality of life: an international multicenter study. Dis Colon Rectum. 2014;57:585–91.
68. Juul T, Ahlberg M, Biondo S, et al. International validation of the low anterior resection syndrome score. Ann Surg. 2014;259:728–34.